This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015-2019.
Location History:
- Rockville, MD (US) (2015)
- Gaithersburg, MD (US) (2019)
Company Filing History:
Years Active: 2015-2019
Title: Christopher Micklitsch: Innovator in Nucleic Acid Detection
Introduction
Christopher Micklitsch is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of nucleic acid detection, holding 2 patents that showcase his innovative approaches.
Latest Patents
Micklitsch's latest patents include "Cyclopentane-peptide nucleic acids for qualitative and quantitative detection of nucleic acids." This invention focuses on methods for detecting a nucleic acid of interest in a solution. The process involves using PNA capture and reporter probes that are designed to bind to specific nucleic acid sequences. The detection method is capable of identifying the nucleic acid when as few as 1-1000 molecules are present in the tested solution.
Another significant patent is "Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens." This method aims to lower the detection limit for nucleic acids by utilizing a substrate with affixed PNAs. The approach enhances the sensitivity of detection assays and includes a kit for identifying target nucleic acids.
Career Highlights
Christopher Micklitsch works for the United States of America, as Represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the methodologies used in nucleic acid detection, contributing to both research and practical applications in health and diagnostics.
Collaborations
Micklitsch has collaborated with notable colleagues such as Daniel H Appella and Chao Zhao. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in his field.
Conclusion
Christopher Micklitsch is a distinguished inventor whose work in nucleic acid detection has the potential to impact various scientific and medical fields. His patents reflect a commitment to advancing detection technologies, making significant strides in the understanding and identification of nucleic acids.